BPC-157 Raw Material

Overview

BPC-157 (Body Protection Compound-157; also designated PL 14736) is a synthetic pentadecapeptide consisting of 15 amino acids (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val). It is derived from a partial sequence of the body protection compound isolated from human gastric juice. Unlike endogenous gastric proteins, BPC-157 is stable under physiological conditions and resistant to enzymatic degradation in the gastrointestinal tract, making it suitable for research across both systemic and local tissue-repair models. It has been studied in hundreds of published animal experiments covering gastrointestinal, musculoskeletal, neurological, and vascular systems.

Technical Specifications

Key Research Findings

The most extensively documented application of BPC-157 in animal research is gastrointestinal mucosal protection and repair. A comprehensive review by Sikiric et al. (2011) consolidating over two decades of preclinical data demonstrated consistent cytoprotective and healing effects across models of gastric ulceration, inflammatory bowel disease, intestinal anastomosis, and fistula formation — mediated in part through upregulation of growth hormone receptor expression and nitric oxide synthesis [1]. The gastric stability of BPC-157 (unlike most peptides) allows it to remain biologically active throughout the GI tract, which researchers note as a key factor in its oral and parenteral study designs.

In musculoskeletal research, Chang et al. (2011) demonstrated in tendon outgrowth models that BPC-157 significantly accelerated tendon healing by promoting cell survival, proliferation, and directed migration at the injury site — effects attributed in part to modulation of the VEGF signaling pathway [2]. These findings have made BPC-157 a widely referenced compound in regenerative research programs focused on tendon, ligament, muscle, and bone repair. Its activity profile across both soft tissue and hard tissue repair endpoints distinguishes it from single-pathway repair peptides.

Why Purity Matters

BPC-157’s 15-amino acid sequence includes three consecutive proline residues (positions 3–5), which are structurally critical to its bioactive conformation. Synthetic impurities — particularly sequence deletions, racemized residues, or failed coupling products from solid-phase synthesis — can alter the peptide’s three-dimensional folding and reduce or abolish receptor interaction. For research institutions incorporating BPC-157 into multi-variable animal studies, or for manufacturers preparing it for inclusion in formulation pipelines, batch-verified HPLC purity at ≥99.9% ensures that observed biological effects are attributable to the compound and not to structural variants within the material.

References:
[1] Sikiric P, et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Curr Pharm Des. 2011;17(16):1612–32. PMID: 21548867
[2] Chang CH, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol. 2011;110(3):774–80. PMID: 21148341

Quality & Documentation

Each batch of BPC-157 raw material is individually tested before shipment. Included with every order:

• HPLC purity verification (≥99.9%)
• Mass spectrometry (MS) identity confirmation
• Batch number for full traceability

COA available upon request before order commitment.

FAQ

Q: Is BPC-157 available in liquid formulation?
Yes, liquid formulation is available on request. Please specify your preferred concentration and solvent when inquiring.

Q: How should BPC-157 raw material be stored?
Store at −20°C, sealed, away from light and moisture. Shelf life is 24 months under proper conditions.

Q: Is BPC-157 the same as PL 14736?
Yes. PL 14736 is a research designation used in some published literature and clinical trial registries for the same pentadecapeptide compound (CAS 137525-51-0).